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Abstract
Background: Propriospinal neurons, with axonal projections intrinsic to the spinal cord, have shown a greater
regenerative response than supraspinal neurons after axotomy due to spinal cord injury (SCI). Our previous work
focused on the response of axotomized short thoracic propriospinal (TPS) neurons following a low thoracic SCI (T9
spinal transection or moderate spinal contusion injury) in the rat. The present investigation analyzes the intrinsic
response of cervical propriospinal neurons having long descending axons which project into the lumbosacral
enlargement, long descending propriospinal tract (LDPT) axons. These neurons also were axotomized by T9 spinal
injury in the same animals used in our previous study.
Results: Utilizing laser microdissection (LMD), qRT-PCR, and immunohistochemistry, we studied LDPT neurons
(located in the C5-C6 spinal segments) between 3-days, and 1-month following a low thoracic (T9) spinal cord
injury. We examined the response of 89 genes related to growth factors, cell surface receptors, apoptosis, axonal
regeneration, and neuroprotection/cell survival. We found a strong and significant down-regulation of ~25% of the
genes analyzed early after injury (3-days post-injury) with a sustained down-regulation in most instances. In the few
genes that were up-regulated (Actb, Atf3, Frs2, Hspb1, Nrap, Stat1) post-axotomy, the expression for all but one
was down-regulated by 2-weeks post-injury. We also compared the uninjured TPS control neurons to the uninjured
LDPT neurons used in this experiment for phenotypic differences between these two subpopulations of
propriospinal neurons. We found significant differences in expression in 37 of the 84 genes examined between
these two subpopulations of propriospinal neurons with LDPT neurons exhibiting a significantly higher base line
expression for all but 3 of these genes compared to TPS neurons.
Conclusions: Taken collectively these data indicate a broad overall down-regulation in the genes examined,
including genes for neurotrophic/growth factor receptors as well as for several growth factors. There was a lack of
a significant regenerative response, with the exception of an up-regulation of Atf3 and early up-regulation of
Hspb1 (Hsp27), both involved in cell stress/neuroprotection as well as axonal regeneration. There was no indication
of a cell death response over the first month post-injury. In addition, there appear to be significant phenotypic
differences between uninjured TPS and LDPT neurons, which may partly account for the differences observed in
their post-axotomy responses. The findings in this current study stand in stark contrast to the findings from our
previous work on TPS neurons. This suggests that different approaches will be needed to enhance the capacity for
each population of propriospinal neuron to survive and undergo successful axonal regeneration after SCI.
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Most research on axonal regeneration after spinal cord
injury has studied the regenerative ability of supraspinal
neurons (SSNs), neurons located in the brain which
have axonal projections into the spinal cord (i.e. corti-
cospinal tract, respiratory bulbospinal, rubrospinal tract,
vestibulospinal tract, and reticulospinal tract neurons).
Particularly corticospinal tract axons have demonstrated
a limited regenerative ability after spinal injury [1]. This
is also the case for axons of other SSNs in the brain-
stem, particularly after axotomy at more caudal levels of
the spinal cord (i.e. thoracic), although a regenerative
response is sometimes found [2]. Regeneration is even
limited when tested within environments known to be
permissive to regeneration [3,4]. Some of the earliest
studies showing that central nervous system axons have
the capacity to regenerate in an appropriate environ-
ment were the seminal studies from Agauyo’s laboratory
showing propriospinal (PS) axons, damaged by nearby
peripheral nerve graft insertion, were able to grow
within peripheral nerve grafts [5,6]. Propriospinal axons
had a more robust regenerative response in this instance
t h a nS S Na x o n s ,a sw e l la si nl a t e rs t u d i e su s i n go t h e r
permissive environments such as cellular bridges/grafts
enriched in growth factors [7-9].
PS neurons, are a class of neuron intrinsic to the spinal
cord, and have remained relatively understudied in regards
to axonal regeneration. PS neurons can be divided into a
variety of classes. Short thoracic PS (TPS) neurons arise
from the thoracic levels of spinal cord and their axons pro-
ject for a few segments in the rostral and caudal directions.
TPS neurons primarily are involved in regulating axial
musculature and postural mechanisms [10]. Long distance
PS neurons, include long ascending propriospinal tract
neurons found in the lumbosacral enlargement that project
rostrally to the cervical enlargement, and long descending
propriospinal tract (LDPT) neurons found in the cervical
enlargement projecting mainly caudally to the lumbosacral
enlargement. These different classes of long distance PS
neurons send reciprocal projections between the limb seg-
ments and function in the regulation and fine-tuning of
locomotion, limb coordination, and postural support, work-
ing in concert with SSNs [10]. In addition to the robust
regenerative response that PS neurons exhibit following
experimental axotomy [5-9,11,12], PS axons also appear to
undergo a considerable amount of post-injury axonal plas-
ticity. For instance, after partial surgical spinal injury,
remaining intact propriospinal projections have been able
to form functional neuronal bypass circuits caudal to the
site of injury related to recovery of motor functions [12-14].
We recently studied the intrinsic response of TPS
neurons using laser micro-dissection of pre-labelled TPS
neurons at different periods (3-days, 1-week, 2-weeks, 1-
month) after low thoracic spinal transection followed by
gene microarray, qRT-PCR, and immunohistochemical
analyses [15]. We identified a number of factors that
may be related to differences in regenerative ability
when comparing our findings with previous studies of
SSNs. One difference was the large local inflammatory
response seen 3-days post-axotomy in TPS neurons not
described in most studies of SSNs after spinal injury
[15]. In addition, many genes associated with axonal
regeneration, and with a number of growth factor recep-
tors (i.e. Gfra1, Ret, Lifr) were up-regulated acutely in
axotomized TPS neurons [15]. We believe that the suc-
cessful propriospinal regeneration found in previous stu-
dies [5-9] is the product botho ft h i se a r l yr e g e n e r a t i v e
response, as well as the ability to respond to neuro-
trophic/growth factors present in the implanted grafts.
Besides sustaining regeneration, neurotrophic or growth
factors present in the grafts may have protected locally
axotomized TPS neurons from the strong apoptotic
response seen in TPS neurons 3-days post-SCI in our
previous study.
In the present investigation we analyzed pre-labelled
LDPT neurons collected from the C5-C6 cervical spinal
segments from the same animals used in our previous
TPS study [15] using a similar genetic and immunohis-
tochemical approach. We hypothesized that a similar
robust regenerative response would be found in the
LDPT neurons, but possibly at a more delayed period
post-injury. However upon analysis, we were surprised
to find a much smaller response to axotomy of LDPT
neurons including the lack of a cell death or an obvious
regenerative response, and down-regulation in many of
the genes assessed by our qRT-PCR analysis. Instead of
mounting the robust early response exhibited by TPS
neurons, LDPT neurons appear to enter a state of rela-
tive dormancy or quiescence. These differences observed
in the post-injury response led us to compare PCR array
data from uninjured cervical controls in the present ana-
lysis, with PCR array data from uninjured thoracic con-
trols available from our previous study [15]. This
comparison revealed unexpected phenotypic differences
between TPS neurons and LDPT neurons that may be
one of several factors contributing to the differences in
the post-axotomy response between these two popula-
tions of PS neurons.
Methods
All procedures utilizing animals were approved by the
SUNY Upstate Medical University Committee for the
Humane Use of Animals, under the direction and guide-
lines of the institutional Department of Laboratory Ani-
mal Research and the Association for Assessment and
Accreditation of Laboratory Animal Care.
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Page 2 of 17Female hooded Long-Evans rats (N = 36, Simonsen;
Santa Clara; CA) approximately 77 days (± 10 days) old
were used in this study. Animals were assigned to var-
ious labelling, injury, and survival time-points (see Table
1 for group assignments).
Animal Surgeries
Retrograde Labelling of Cervical Long Descending
Propriospinal Tract (LDPT) Neurons
Retrograde labelling of LDPT neurons was performed as
previously described [15]. In brief, animals were
anesthetized by an intraperitoneal injection of a keta-
mine/xylazine cocktail (0.07 cc/100 g). A laminectomy
was made at vertebral level T-13 exposing the upper
lumbosacral enlargement. Following exposure, six 0.30
μl Fluorogold (FG; Biotinum Inc; Hayward; CA; 3% w/v
in dH2O) or Dextran Tetramethyl Rhodamine 3,000 M.
W. (DTMR; Molecular Probes; Eugene; OR; 1% w/v in
1× PBS) injections were made bilaterally centered within
the intermediate gray matter (laminae V - VIII) at the
rostral, middle, and caudal aspects of the laminectomy
site.
Spinal Transection
Spinal transection surgeries were performed one-week
post-retrograde labelling, as described in [15]. In brief,
following anaesthesia a laminectomy was performed at
the T9 vertebral level. A pair of iridectomy scissors
(Fine Scientific Tools; Foster City; CA) was used to
completely transect the spinal cord. Following transec-
tion, a probe was scraped along the inner wall of the
vertebral canal through the lesion site to further ensure
a complete lesion.
Spinal Contusion
Using the same procedures that are described in detail
in [15], some animals were subjected to a spinal contu-
sion injury. In brief, animals were anesthetized, and a
laminectomy was performed at the T9 vertebral level.
Then a moderate spinal contusion injury was inflicted
by dropping a 10 g rod from a height of 25 mm onto
the exposed cord, using the NYU Impactor and MAS-
CIS protocol [16,17].
Post Operative Care
Following all surgical procedures, the incisions were
closed in anatomical layers, using 3.0 silk to close the
musculature, and 3.0 Nylon to close the skin; external
sutures were removed after the first post-operative
week. All spinal injured animals had their bladders
expressed twice daily until the micturition reflex
returned, and injections of Cefazolin (Sandoz Inc; Prin-
ceton, NJ; 0.03 cc, s.q.) were given b.i.d. for the first
week following spinal injury to prevent urinary tract
infections, or when infections occurred. For the first 48-
hours post-operatively Buprenorphine hydrochloride
(Buprenex injectable; Ben Venue Laboratories Inc; Bed-
ford, OH; 0.03 cc s.q.) was given b.i.d. for pain manage-
ment. All post-operative animals had ad libitum access
to both food and water.
Histology and Immunohistochemistry
DTMR Tissue
Animals were euthanized by an injection of sodium pen-
tobarbital (Fatal Plus, 0.5 cc), and transcardially perfused
with 500 ml 0.1 M PBS (pH 7.4) followed by 500 ml 4%
paraformaldehyde (pH 7.4). Spinal cords were post-fixed
in 4% paraformaldehyde for at least 24-hours followed
by cryoprotection in 20% sucrose for a minimum of 24-
hours. Tissue samples were embedded in O.C.T com-
pound (Tissue Tek® embedding medium) and frozen on
dry ice. Tissue was sectioned on a cryostat in the trans-
verse plane at a thickness of 20 μm. Slides were main-
tained at -20°C until further processing.
Immunohistochemistry
DTMR and FG retrogradely labelled LDPT neurons
were probed immunohistochemically for the expression
Table 1 Animal and Experimental Group Assignments
Animal Group N Label Injury Type Survival Time Post-injury Total Survival Post-Labelling Group Comparisons
1 4 FG No —— 7 days 1 to 4
2 4 FG No —— 2 weeks 1 to 5
3 4 FG No —— 1 month 2 to 6
4 4 FG Yes Txn 3 days 10 days 3 to 7
5 4 FG Yes Txn 1 week 2 weeks 8 to 9
6 4 FG Yes Txn 2 weeks 3 weeks
7 4 FG Yes Txn 1 month 5 weeks
8 4 DTMR No —— 2 weeks
9 4 DTMR Yes Con 1 week 2 weeks
Animal Group Assignments. Female Long-Evans rat were divided among 9 groups. Using the indicated tracer, Fluorogold (FG) or Dextran Tetramethyl Rhodamine
(DTMR), TPS neurons were prelabelled by a series of bilateral injections into the upper lumbrosacral enlargement. Allowing 1-week for tracer transport, animals in
groups 4-8 were subjected to either a T9 complete spinal transection (Txn) or moderate spinal contusion injury (25 mm weight drop, NYU Impactor; Con).
Following spinal cord injury, animals were allowed to recover for the indicated period of time. The final column of this table indicates the time point
comparisons that were made for both the gene and PCR validation studies conducted during this study
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Santa-Cruz, CA).) 1:250. Slides for ATF-3 labelling were
subjected to an antigen retrieval step (15-min at 95°C in
Citric acid buffer; pH = 6.0) prior to incubation in the
primary antibody over night at 4°C. Secondary antibody
detection of ATF-3 labelling utilized a goat-anti-rabbit-
AlexaFluor488 (1:500; Invitrogen; Carlsbad; CA). All
sides were coverslipped with Vectashield (Vector Labs
Inc; Burlingame; CA). DTMR retrogradely labelled
LDPT neurons were also probed for signs of cell death
using a TUNEL assay kit (R&D Systems; Minneapolis,
MN) following the provided protocols.
Fluorescent Microscopy
All immunohistochemistry was visualized on a Zeiss Axio
Imager A.1 microscope (Carl Zeiss; Germany). DTMR
labelling was viewed under a CY3 filter, FG labelling
under a UV filter, and the immunofluoresence was visua-
lized under a FITC filter. All images were captured using
a SPOT RT slider camera, model 2.3.1 (Diagnostic
Instruments; Sterling Heights; MI). All digitized images
where processed in the Spot™ Advanced software (v. 3.3.4
for Macintosh, Diagnostic Instruments Inc.), and
adjusted for both image brightness and contrast. No
other manipulations were made to these images.
Laser Microdissection and Expression Analysis of LDPT
Neurons
FG Tissue
Following appropriate post-operative recovery time, ani-
mals were euthanized by an i.p. injection of sodium pen-
tobarbital (Fatal Plus, 0.5 cc) and then decapitated. The
lower half of the cervical enlargement, C5-C7, was
rapidly dissected, embedded in O.C.T compound (Tissue
Tek®), and frozen on dry ice. Tissue samples were stored
at -80°C until processing. Tissue sections were cut on a
cryostat transversely at 16 μm and mounted on poly-
ethylennaphtalae (PEN) foil slides (Leica; Wetzar; Ger-
many). Slides were maintained at -20°C during the
sectioning process and stored at -80°C overnight prior
to laser microdissection (LMD).
LMD
Dissection of individual retrogradely labelled LDPT neu-
rons was conducted in the manner described in [15]. In
brief, sections on PEN foil slides were removed from
storage and maintained on dry ice until used for LMD.
Slides were positioned on the stage of a Leica AS LMD
microscope (Leica Microsystems; Bannockburn; IL) and
neurons located within the intermediate gray matter
(Lamina V-VIII and X) were dissected over a period of
10-minutes and collected into nuclease-free PCR tubes
containing 30 μl RLT Lysis Buffer (Qiagen, Valencia;
CA) with 1% b-marcaptoethanol (Sigma Aldrich; St.
Louis; MO). A minimum of 200 FG labelled neurons
were collected from each animal.
RNA Purification & Amplification
Neurons collected by LMD were sent to our institution’s
microarray core facility for purification and amplifica-
tion. Total RNA was purified using the RNeasy Mini kit
(Qiagen; Valencia, CA). The RNA concentration and
quality was determined by loading 1 μl of each sample
onto an RNA 6000 Pico Chip (Agilent Technologies).
qRT-PCR
The reverse transcriptase (RT) reaction to convert the
RNA into first strand cDNA for PCR was carried out
using the RT
2 First Strand Kit (SA Biosciences; Freder-
ick; MD) following the manufacturer’s directions and
the supplied reagents for each RNA sample. PCR was
performed using the RT
2 SYBR Green qPCR Master
Mix and RT
2 Profiler™ PCR Array for Rat Neurotrophins
and Receptors (SA Biosciences; Frederick; MD), accord-
ing to manufacturer’s instructions. Additional custom
PCR primers were designed for 28 additional specific
genes of interest (GOI), using the Primer3 software [18]
(http://frodo.wi.mit.edu/primer3; See Table 2) and
ordered from Eurofins MWG Operon. RNA for these
custom-designed PCR reactions was converted into
cDNA and pre-amplified for PCR using the Ovation ™
RNA Amplification System (NuGen; San Carlos; CA).
These PCR reactions were performed using a SybrGreen
I Master Mix (Roche). Both the SA Biosciences PCR
arrays and SybrGreen I PCR reactions were run in
duplicate for each cDNA template on the LightCycler
480 (Roche).
qRT-PCR Data Analysis
The average number of cycles required for a gene to
reach the crossing point (Cp) above background, in both
the uninjured controls and spinally transected animals,
was calculated and then compared to the mean Cp of
one or more reference genes included on the PCR array
(Rlpl1, Ldha). In the cases where we custom designed
PCR primers, the average Cp values were compared to
the Cp value of the reference gene glyceraldehyde 3-
phosphate dehydrogenase (Gadph), to give us the ΔCp
value. The ΔCp value for each gene of the spinally
transected group was then subtracted from the mean
ΔCp value of the control group to yield the ΔΔCp, from
which the directional and fold changes in our GOI were
determined. All non-reference genes that generated Cp
values less than 40 cycles in at least two samples within
a given lesion or control group (n = 89 out of 113) were
subjected to a 2 way ANOVA (Treatment × Time) to
detect those with a significant main effect of Treatment,
or a significant Treatment × Time interaction. To cor-
rect for multiple testing, the significance threshold for
these analyses was adjusted using the Benjamini-Hoch-
berg False Discover Rate (FDR) set to 0.10. After FDR
correction, the expression data for all genes with a sig-
nificant main effect of Treatment (n = 27; Table 3) were
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clustering (Figure 1).
Results
Overall Response of LDPT Neurons to a T9 Level Spinal
Cord Injury
A 2-way ANOVA (Treatment × Time) was used to
determine which of the 89 genes that could be analyzed
from our original data set (see qRT-PCR, Methods)
exhibited a significant change in expression due to the
main effect of treatment (See Methods). Following cor-
rection for multiple testing (see qRT-PCR Methods)
only 18 were found to be significant to the P ≤ 0.05
level, while an additional 9 genes reached a level of
nominal significance (See Table 3). When the -ΔΔCp
values were determined to indicate direction of change,
the results were unexpected. As illustrated in Figure 1,
13 of the 18 genes that demonstrated a significant
change in expression and 6 of the 9 genes that had a
nominally significant change exhibited an immediate
down-regulation post-axotomy. Of these 19 genes show-
ing an immediate down-regulation, 2 are related to
apoptosis (Casp2, Pycard); 4 are neuropeptides (Cckar,
HcRt, Grpr, Npffr2), regulate energy metabolism (HcRt),
pain modulation (Grpr, Npffr2), and endorphin/dopa-
mine release (Cckar); 7 are neurotrophic factor or other
surface receptors (Adycap1r1, Crhr1, Galr2, Gfra1,
Gfra2, Gfra3, and Ntrk1 (TrkA)); and 6 are neuro-
trophic agents (Artn, Il1b, Ntf3 (NT-3), Ntf5 (NT-4/5),
Nrg2, and Tgfb1). Interestingly, after the initial down-
regulation of these genes, only Casp2 showed a gradual
increase in expression back towards control levels by 1-
month post-axotomy (column 4 in Figure 1).
While a majority of the genes significantly affected by
axotomy were down regulated, 4 genes exhibited signifi-
cant up-regulation following axotomy, a transcription
factor (Stat1), a growth factor receptor component
(Frs2), an actin-cytoskeletal related protein (Nrap), and
a cell stress and axonal regeneration associated gene
(Hspb1) (Figure 1). The expression profiles for Stat1,
Table 2 PCR Primers
Gene Symbol Accession # Left Primer Right Primer Product Size
Abcb5 XM_234725 CTGATAGAGCATGGCTTTGAATG GGTTGTTTTATGGCAGAGCAGA 77
Akt3 NM_031575 TGGAGAGGAAGAGATGGATGC TCCACTTGCCTTCTCTCGAAC 130
Arg1 NM_017134 TGGAACAATCAGTGTGGTGCT ATCCACCCAAATGACGCATAG 103
Atf3 NM_012912 AATTGCTGCTGCCAAGTGTC CAGTTCGGCATTCACACTCTC 94
Atg9a NM_001014218 CCTTTGCGCAGATGGACGTT ACAACTCGGTCTTCCCATCCT 107
Atg9b XM_575327 CATTCTACCCTCAGCCCAGT GAAGAGATTGCAGACCGAGC 121
Atrn NM_031351 CGTGTGGTCATGTTGGTCA GCACTAGAGCACCTTGAGTTTG 121
Casp2 NM_022522 GTGGAATGCATCCTGACCAT TAACAGTTCGCTCAGCAGCA 83
Crem S67786 CTGGCCAAATTTCTGTCCCTA ACACCTTGTGGCAAAGCAGTA 133
Dbh NM_013158 GGGATGTCCTCATCACTTCG GTGGCCATTGTCCTGTTTTC 55
Flna XM_238167 ACCAACCAACAGTGCAGACC TGTTTGCTGGCTACCCTGAG 80
Fuk XM_226508 AGAGCTCAGGCTCTAGGATGC ACACCACCCATTGCCTATGA 112
Grm4 NM_022666 CCAATGTGCCATCCTCAGA CCTACACCAACCATGCCATC 119
Itga6 XM_215984 GCCCTATGAACTTGGTGGAGA AATACCCTTCCCTGAGTCCACA 100
Itgb1 NM_017022 CCACAACAGCTGCTTCTAAAGTTG AATAGGGTAGTCTTCAGCCCTCTTG 84
Maob NM_013198 TGGTGGATCTGGTCAAGTGAG TCTCCTGTCTGGTCAATGTGG 96
Notch3 NM_008716 TGCAGGGTAGGCTTGGTATG TGTGTCCAGACTGGGGCTTA 79
Nrap NM_001107443 GGCGGCTCTTTTGGCTATC GGGCAGCAGAGAGGGAAAG 72
Oaz1 NM_139081 AGTCAGCGGGATCACAGTCTT AGGACCCTGGTCTTGTCGTTA 98
Pdgfra XM_214030 CGAAGGCAGGCACATTTATATC TATGATGGCACAATCGTCCTCT 109
Pycard NM_172322 GCATACAGGAGCTGGCTGA CAATGAGTGCTTGCCTGTGT 135
Rhoq NM_053522 CTATGCTAACGACGCCTTCC GATAAAGGCCTCAGACGATCA 147
Sat NM_001007667 TGACCCATGGATTGGCAAGT GCAGCGACACTTCATAGCAA 124
Slc27a3 XM_215605 CAGCTCCCCAATGTACTGGA TAGGGGCCACTGTGGTACTG 101
Slc6a11 NM_024372 CCCGTCTTCTTCCTGGAAAC GGACAGACTCTCCTCCAGCA 77
Tgfbr1 NM_012775 TTCATTTCAGAGGGCACCAC CAATGGTCCTTGCAATTGTTC 109
Xiap NM_022231 GAATATGACGCACGGATCGTT CCTCCTCCACAGTGAAAGCAC 128
Zfp53 XM_344861 GCAAACAAGCTGCAGAGTCA TGAGGCGGTACTGAAGCATT 132
PCR Primer Table. Primer sequences for all of the custom designed PCR primers used in this study. Primers were designed using the Primer3 software and
synthesized by Eurofins MWG Operon (see Methods)
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3-days post-injury (column 1) and 1-week post-injury
(column 2), but by 2-weeks post-injury expression of
these 3 genes was down-regulated (column 3). Nrap was
the only gene that remained up-regulated, with maximal
expression appearing 1-month post-injury (column 4).
Atf3 also demonstrated a significant up-regulation post-
axotomy but is not indicated on the heat map (Figure
1). There was a lack of any detectable PCR product
when probing for this gene in the uninjured controls
(resulting in no Cp values), which made calculating
-ΔΔCp values and the accompanying statistics proble-
matic. This lack of Atf3 PCR product in the controls
and presence in spinally injured animals was interpreted
to indicate that Atf3 mRNA was not expressed at a
measurable level in uninjured animals, but was signifi-
cantly up-regulated following injury. The up-regulation
of ATF-3 protein was demonstrated in both the spinally
transected and contused animals. As illustrated in Figure
2A-C, DTMR retrogradely labelled LDPT neurons are
clearly visible (Figure 2a) and there is a lack of any
ATF-3 immunolabelling (Figure 2B,C) in uninjured con-
trol animals. However, when animals that received a
low-thoracic spinal transection (Figures 2D-F), or spinal
contusion (Figures 2G-I) were examined for ATF-3 acti-
vation (examined at 4-days and 1-week post-injury)
there was pronounced ATF-3 immunolabelling (Figures
2E and 2H). As illustrated, retrogradely labelled LDPT
neurons (Figures 2D, and 2G) colocalize with the clear
nuclear ATF-3 immunolabelling (Figures 2E, and 2H)
when the images are overlaid (Figures 2F and 2I). This
immunofluorescent staining experiment confirmed our
PCR findings, in which ATF-3 expression is only found
in the spinally injured animals.
The remaining 4 genes (Npy1r, Tgfa, Actb, Tgfbr1)
were relatively unaffected at early times post-injury, but
exhibited a significant change in expression over time.
As illustrated in Figure 1, the mRNAs for neuropeptide
Table 3 Genes Exhibiting Significant Change in Expression Post-Axotomy
Gene Treat
F
Treat
P
Treat
FDR
Time
F
Time
P
Time
FDR
Intx
F
Intx P Intx
FDR
Gene Name
Tgfb1 39.26 0.0008 0.012 0.37 0.7775 0.975 0.29 0.8294 0.959 Transforming growth factor beta-1
Gfra2 58.9 0.0006 0.013 18.01 0.0041 0.182 5.2 0.0537 0.478 GDNF family receptor alpha-2
Artn 53.09 0.0008 0.014 2.46 0.1782 0.721 3.22 0.1205 0.564 Artemin
Tgfbr1 23.1 0.0005 0.015 11.2 0.0011 0.098 17.34 0.0002 0.018 TGF-beta receptor type-1
Crhr1 39.2 0.0015 0.017 0.94 0.489 0.907 0.92 0.4934 0.878 Corticotropin-releasing factor receptor 1
Npffr2 40.59 0.0014 0.018 3.18 0.1223 0.544 0.47 0.7164 0.996 Neuropeptide FF receptor 2 (G-protein coupled
receptor 74)
Ntf5 166.32 0.0002 0.018 17.61 0.0091 0.162 14.58 0.0128 0.163 Neurotrophin 4/5
Nrap 17.68 0.0023 0.019 1.13 0.3895 0.889 3.53 0.0618 0.458 Nebulin-related-anchoring protein
Adcyap1r1 32.85 0.0023 0.02 3.25 0.1185 0.555 0.84 0.5267 0.868 Pituitary adenylate cyclase-activating polypeptide type I
receptor
HcRt 63.71 0.0005 0.022 8.2 0.0224 0.285 1.89 0.2498 0.717 Orexin (Hypocretin)
Npy1r 29.78 0.0055 0.038 17.98 0.0087 0.194 19.13 0.0078 0.116 Neuropeptide Y receptor type 1
Gfra3 22.14 0.0053 0.039 0.85 0.5251 0.935 9.31 0.0173 0.192 GDNF family receptor alpha-3
Frs2 19.94 0.0066 0.042 17.85 0.0042 0.125 21.47 0.0028 0.083 Fibroblast growth factor receptor substrate 2
Grpr 17.86 0.0083 0.043 0.32 0.8116 0.976 0.71 0.5889 0.92 Gastrin-releasing peptide receptor
Gfra1 16.98 0.0092 0.045 0.34 0.8009 0.976 0.39 0.767 0.922 GDNF family receptor alpha-1
Ntf3 24.74 0.0076 0.045 1.72 0.301 0.893 4.94 0.0785 0.466 Neurotrophin-3
Ntrk1 23.83 0.0081 0.045 8.06 0.0359 0.32 0.45 0.7318 0.972 High affinity nerve growth factor receptor (Trk-A)
Cckar 15.25 0.0113 0.053 0.96 0.4787 0.906 0.46 0.7241 0.991 Cholecystokinin type A receptor
Pycard 9.5 0.0151 0.058 0.52 0.6783 1 1.69 0.2448 0.726 PYD and CARD domain-containing protein
Casp2 9.48 0.0132 0.059 1.38 0.3117 0.895 1.44 0.2955 0.797 Caspase-2
Hspb1 13.15 0.0151 0.061 4.16 0.0794 0.471 15.58 0.0057 0.127 Heat-shock protein 27
Tgfa 11.48 0.0147 0.062 0.31 0.8191 0.959 1.99 0.2174 0.774 Transforming growth factor alpha
Stat4 9.45 0.0218 0.081 0.28 0.8397 0.934 0.08 0.9705 0.993 Signal transducer and activator of transcription 4
Galr2 7.47 0.0257 0.088 4.63 0.037 0.299 1.08 0.4106 0.937 Galanin receptor type 2
Nrg2 6.98 0.0247 0.088 1.19 0.364 0.926 0.61 0.6221 0.955 Pro-neuregulin-2, membrane-bound isoform
Il1b 11.62 0.0271 0.089 2.78 0.1742 0.738 0.91 0.5119 0.876 Interleukin-1 beta
P values for genes exhibiting a significant or nominally significant change in expression post-axotomy. Significant changes in gene expression post-transection
were detected using a 2 way ANOVA. As illustrated above, genes were analyzed for a significant effect of treatment (Treat), Time (Time), and Interaction of
Treatment and Time (Intx). P-values were then corrected for multiple testing applying the Benjamini-Hochberg FDR algorithm, and are arraigned in order of
increasing FDR values based on treatment
Siebert et al. BMC Neuroscience 2010, 11:148
http://www.biomedcentral.com/1471-2202/11/148
Page 6 of 17receptor (Npy1r) and growth factor (Tgfa) are slightly
down-regulated at 1-week post-injury, but are then
strongly down-regulated at later survival times. The
mRNA for b-actin, an actin cytoskeletal element, is up-
regulated at the later time points post-injury (columns 3
and 4; Table 3 shows this up-regulation most clearly).
This up-regulation of Actb has been noted in a number
of investigations post-axotomy [19-21]. The most unique
expression pattern of the 4 genes was for the surface
receptor Tgfbr1, which was significantly down-regulated
post-injury, and then had a complicated pattern of
expression at other survival times.
LDPT Neurons Appear to Lack a Cell Death Response
Following Low Thoracic Spinal Cord Injury
The expression of a number of genes involved in a pro-
or anti-apoptotic response was examined using a series
of PCR primers either included on the array plate, or
custom designed. These primers included Bax, Casp2,
Myc, Ngfrap1, Pycard, and Tp53, all of which are pro-
apoptotic [22-30], while Akt3, Bcl2, Il10, and Xiap are
considered to be anti-apoptotic [31-36]. Only two of
these genes were affected by axotomy/thoracic spinal
injury. As shown in Table 3, Pycard (P = 0.058) and
Casp2 (P = 0.059) showed a nominally significant
change in expression post-axotomy. Moreover, as shown
in Figure 1, both Pycard and Casp2 were down-regu-
lated. Pycard remained down-regulated throughout the
period examined, whereas the levels of Casp2 showed a
gradual increase in expression, approaching baseline
levels (indicated by black) at later survival times. In
addition to the down-regulation of these two pro-apop-
t o t i ce l e m e n t s ,t h el a c ko fa n yc h a n g ei ne x p r e s s i o no f
the other pro-apoptotic or anti-apoptotic genes strongly
suggests that LDPT neurons are not mounting a pro- or
anti-apoptotic response to a T9 level axotomy over the
time course examined. Additionally, two genes regulat-
ing the formation of autophagic vesicles, signs of
homeostatic stress or autophagocytosis, Atg9a and
Atg9b [37,38], also failed to show a significant change in
expression over the time course examined post-
axotomy.
To further examine the evidence for an injury-induced
apoptotic response, we also analyzed retrogradely
labelled neurons immunohistochemically using the
TUNEL assay. This was performed on tissue sections
taken from C5-C6 spinal segments containing labelled
LDPT neurons and the T6-T7 spinal segments contain-
ing labelled TPS neurons 1-week following a T9 moder-
ate spinal contusion injury. As illustrated in Figure 3,
there was co-localization of TUNEL staining within
labelled TPS neurons (Figure 3A, C, E). This result sup-
ports our previous findings showing a strong early cell
death response of TPS neurons following T9 level injury
Figure 1 Genes exhibiting a significant change in expression
post-axotomy. The expression profiles illustrate the normalized
-ΔΔCp expression values compared to controls, with low expression
values being represented by green and high expression in red.
Significant changes in expression were determined using a 2-factor
ANOVA, and then cluster analysis to reveal patterns in the
expression profiles 3-days, 1-week, 2-weeks, and 4-weeks post-low
thoracic spinal transection, numbered 1-4, respectively. As illustrated
in this heat map, 19/27 genes exhibited an immediate down-
regulation following axotomy. 18/19 genes remained down-
regulated following axotomy except Casp2 which exhibited a slow
return to baseline level at 1-month post-injury (column 4). Only two
genes, Actb and Nrap, both of which are actin-cytoskeletal related,
exhibited an up-regulation following axotomy which was
maintained throughout the interval examined. The remaining 6
genes, Stat1, Frs2, Hspb1, Tgfa, Npy1r, and Tgfb1, either exhibited
no response, or an up-regulation following axotomy, followed by a
significant down-regulation by 2-weeks post-injury (column 3).
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Page 7 of 17[15]. However sections from the cervical enlargement
had little TUNEL labelling and little to no co-localiza-
tion of the TUNEL labelling within retrogradely labelled
LDPT neurons (Figure 3B, D, F). The TUNEL findings
complement the PCR data, and further argue that LDPT
neurons do not undergo a significant amount of post-
axotomy retrograde cell death.
Phenotypic Differences Exist Between Uninjured TPS and
LDPT Neurons
T h er e s u l t so ft h ep r e s e n ts t u d yi n d i c a t et h a tL D P T
neurons respond very differently compared to TPS neu-
rons [15] after the same low thoracic spinal transection.
Based on these observations, we were prompted to
determine if there were any fundamental baseline
differences between these two populations of PS neu-
rons that could underlie their strikingly different tran-
scriptional responses to the same injury. To begin to
e x a m i n et h i si s s u e ,w ec o m p a r e dt h eP C Ra r r a yp l a t e
data from neurons collected from uninjured cervical
controls and uninjured thoracic controls from our pre-
vious study [15]. Since the RNA samples were collected
and purified in the same manner, and the RT reaction
and PCR array plates were identical for both studies (see
M e t h o d s ) ,w ew e r ea b l et oc o m p a r et h ep r e v i o u s l yg e n -
erated Cp values from the thoracic control animals with
the cervical control animal Cp values generated in the
present study.
The analysis of the control PCR data was conducted
in a manner similar to that already mentioned in the
Figure 2 Post-injury expression of ATF-3. One gene of interest that was examined using PCR was ATF-3. However due to the lack of PCR
reaction product in the control animals and presence of PCR reaction product in the experimental animals, calculation of -ΔΔCp values and
statistics was problematic. Therefore we probed for expression of ATF-3 protein immunohistochemically. A, C: In uninjured control animals a
DTMR labelled LDPT neuron is clearly visible (red) and there is a lack of any ATF-3 labelling (B; green). D, E, F However, when an animal that
received a complete T-9 spinal transection was examined 4-days post-injury, the FG labelled LDPT neuron (D; in yellow) colocalizes with the
nuclear ATF-3 labelling shown in green (E, F). G, H, I Moreover, when animals that received a T-9 spinal contusion injury are examined 1-week
post-injury, the DTMR labelled LDPT neurons (G; in red), again, colocalize with the ATF-3 labelling (H; in green). These findings complement the
PCR findings indicating an up-regulation of ATF-3 post-SCI. CNT = Uninjured Control, TXN = Transection, CON = Contusion. Scale Bars = 50 μm
Siebert et al. BMC Neuroscience 2010, 11:148
http://www.biomedcentral.com/1471-2202/11/148
Page 8 of 17Methods section with some minor modifications. In
brief, once all Cp values were determined, they were
compared to the average Cp of four reference genes
included on the PCR array (Hprt, Ldha, Rplp1, and
Rpl13a) to give us the ΔCp value. Then for each gene
the ΔCp value of the thoracic control group (TPS neu-
rons, retrogradely labelled for 1-week, 2-weeks, or 1-
month after injection of FG) was subtracted from the
mean ΔCp value of the cervical control group (LDPT
neurons, retrogradely labelled for the same time periods
as TPS neurons) to yield the ΔΔCp. The ΔΔCp values
were then used to indicate the direction and fold
differences in gene expression between the uninjured
LDPT and TPS neurons that served as controls in the
present and previous study, respectively.
T h eP C Ra r r a yd a t aw e r ea n a l y z e du s i n ga2w a y
ANOVA (Treatment × Time) to detect genes with a sig-
nificant main effect of level. The significance threshold
for these analyses then was adjusted using the Benja-
mini-Hochberg FDR set to 0.10. Genes with a significant
main effect of level were subjected to a Welch’st - t e s t
post-hoc to determine at which specific time points (1-
week, 2-weeks, or 1-month post-FG labelling) the differ-
ence in expression was significant. The unadjusted
P-values, FDR corrected P-values and post-hoc test
P-values were then compiled and are presented in Table 4.
As illustrated in Table 4, 31 of the 84 genes on the
PCR array plate demonstrated a significant difference in
expression level between the cervical and thoracic sam-
ples. Eight of these genes encode neurotrophic/growth
factor receptors (Lifr, Crhr1, Gfra2, Gfra1, Ntrk2, Ntrk1,
Cntfr, and Adcyap1r1), and 7 encode agents that
enhance neuronal survival or axonal regeneration
(Hspb1, Ntf5, Tgfa, Zfp91, Artn, Tgfb1, and Mt3).
Twelve of 16 of the other genes demonstrating a signifi-
cant difference in expression regulate axonal branching
(Nf1; [39]); are various neuropeptides/neuropeptide
receptors (Hcrt, Npffr2, Npy1r, Npy, Ppyr1); regulate
transcription (Fus, Stat1 and Zfp110); modulate cellular
signalling (Frs2); regulate apoptosis (Tp53); or is
involved with nervous system development (Fgfr1). One
finding that was unexpected was the significant differ-
ence in expression level of the reference genes used on
the array plate (Ldha, Rplp1, Hprt, and Rpl13a). Even
though the average of the 4 reference genes was used to
calculate the ΔCp values, they still exhibited a significant
difference in expression between cervical and thoracic
spinal cord. Since the other PCR Array plate control
probe data (Rat Genomic DNA Contamination Control,
Reverse Transcription Control, and Reverse Transcrip-
tion Control) did not differ between plates used for the
TPS and LDPT analyses, these data appear valid. As
shown in Table 4, 28 of the 31 genes in the PCR array
that were significantly different between propriospinal
neurons collected from the thoracic or the cervical
spinal cord were more highly expressed in cervical neu-
rons. Only Ldha and Hprt, two of the reference genes,
and metallothionein (Mt3) exhibited a higher expression
level in thoracic neurons.
Discussion
This study is the first to our knowledge to specifically
study the post-axotomy response of LDPT neurons.
Rather than focusing on the response during the first 24
hours post-axotomy, we began our analysis 3-days post-
injury (p.i.), and continued at different periods up to
Figure 3 TUNEL Staining. To further explore the difference in the
cell death response that was observed in the LDPT neurons
compared to what was found in our previous TPS study, we utilized
a TUNEL assay kit to examine for signs of cell death 1-week
following T9 level contusion. A, C, E, DTMR retrogradely labelled
TPS neurons probed with the TUNEL assay kit show colocalization
of a TUNEL labelled nucleus within a retrogradely labelled TPS
neuron, additionally, multiple TUNEL labelled nuclei are present in
the merged image, possibly glial cells or interneurons, not
retrogradely labelled by TMR. B, D, F, However, when cervical spinal
cord is examined, while DTMR retrogradely labelled LDPT neurons
are clearly visible, no signs of TUNEL labelling are observed in
neurons, or in the surrounding tissue. Scale Bars = 50 μm
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analyzed in most previous studies [11,40-44]. Just as was
done in our TPS study, we used LMD to specifically col-
lect individual FG retrogradely pre-labelled LDPT neu-
rons at different times after axotomy. Therefore, the
mRNA collected was from a relatively pure sample lim-
ited predominantly to LDPT neurons. Again as with our
previous TPS study, one potential criticism is the use of
Fluorogold (FG) to retrogradely pre-label our LDPT
neurons. It has been suggested that FG may have cyto-
toxic effects on neurons over time [45,46]. However as
reported in our previous study [15], no significant
changes in gene expression were found comparing our
control groups at the various post-FG labelling time
points (1-week, 2-weeks, or 1-month). Moreover, there
was no evidence (genetically or immunofluorescently) of
a pro-apoptotic response in these control groups during
the first month following SCI. These findings support
the argument that FG labelling has no adverse effects on
neurons, and is a suitable neuronal tracer for this type
of study.
While this study did not utilize the gene microarray
analysis used in our TPS study [15], we analyzed the
post-axotomy response of LDPT neurons using qRT-
PCR arrays and custom-designed primers for a number
of categories of genes, including many of the same
genes that were analyzed by qRT-PCR in the TPS study.
Moreover, the spinal tissue examined was from the
Table 4 Phenotypic Differences Between Thoracic and Cervical Propriospinal Neurons
Fold Chg Individual Fold Chg Post hoc P value
Gene Level F Level P FDR ΔΔCp Cerv-Thor Time1 Time2 Time3 Time1 Time2 Time3
Hspb1 159.50 0.00002 0.001 -3.67 12.8 0.9 43.2 50.9 0.9273 0.0426 0.0833
Lifr 142.15 0.00002 0.001 -3.31 9.9 7.2 6.3 21.7 0.062 0.0273 0.0029
Ldha 104.55 0.00005 0.001 3.06 0.1 0.1 0.2 0.1 2E-05 0.0003 0.0062
Rplp1 82.46 0.00010 0.001 -3.55 11.7 10.2 8.9 17.7 6E-06 0.0004 0.0001
Nf1 53.07 0.00030 0.004 -2.29 4.9 1.4 4.0 20.6 0.7123 0.0375 0.0509
Ntf5 52.54 0.00040 0.004 -5.52 46.0 14.5 48.6 138.2 0.0027 0.0139 0.0107
Crhr1 34.54 0.00110 0.009 -5.69 51.5 7.8 88.0 198.9 0.0633 0.0091 0.0073
Gfra2 34.36 0.00110 0.008 -2.54 5.8 1.2 8.8 18.4 0.6241 0.1267 0.0388
Gfra1 26.31 0.00220 0.014 -3.29 9.8 3.8 12.1 20.5 0.3976 0.0122 0.002
HcRt 20.89 0.00380 0.022 -7.96 248.3 29.1 857.7 614.3 0.0049 0.0159 0.0079
Ntrk2 19.49 0.00450 0.024 -0.22 1.2 0.7 1.1 2.2 0.5642 0.9113 0.5394
Zfp110 19.21 0.00470 0.023 -2.74 6.7 2.9 8.5 12.3 0.2716 0.0457 0.1485
Tp53 17.61 0.00570 0.026 -2.49 5.6 5.1 5.5 6.3 0.1686 0.0759 0.1054
Tgfa 16.48 0.00670 0.028 -3.99 15.9 3.5 21.7 53.0 0.0804 0.0008 0.0015
Ntrk1 14.67 0.00870 0.034 -5.98 63.3 19.7 106.5 120.6 0.0049 0.0006 0.0006
Zfp91 14.44 0.00900 0.033 -1.70 3.2 1.4 3.0 8.0 0.5574 0.252 0.0011
Npffr2 13.86 0.00980 0.034 -4.59 24.1 9.3 19.3 78.0 0.0283 0.0038 0.0007
Artn 13.89 0.00980 0.032 -6.97 125.4 21.8 335.2 270.2 0.0017 0.0482 0.0045
Npy1r 13.61 0.01020 0.032 -5.44 43.3 4.9 89.2 184.5 0.1173 0.0017 0.0002
Fgfr1 12.28 0.01280 0.038 -1.33 2.5 1.6 3.4 3.0 0.3199 0.0554 0.1921
Stat1 11.92 0.01360 0.038 -0.54 1.5 0.2 8.0 1.9 0.2964 0.0022 0.7465
Fus 10.51 0.01760 0.047 -1.56 3.0 1.7 2.0 7.3 0.066 0.1028 0.0051
Cntfr 10.26 0.01850 0.047 -0.52 1.4 1.6 0.9 2.2 0.5502 0.8505 0.4669
Npy 10.16 0.01890 0.046 -1.45 2.7 0.9 2.9 8.2 0.8662 0.0062 0.0459
Frs2 9.82 0.02020 0.048 -1.22 2.3 0.8 3.4 4.8 0.8758 0.0124 0.3093
Adcyap1r1 9.22 0.02290 0.052 -4.42 21.5 9.0 27.6 39.9 0.0268 0.0043 9E-05
Hprt 9.22 0.02290 0.050 2.19 0.2 0.2 0.2 0.3 0.0719 0.0575 0.002
Ppyr1 7.79 0.03150 0.066 -6.86 116.2 31.2 69.5 723.5 0.1673 0.0261 0.0019
Tgfb1 7.65 0.03260 0.066 -3.84 14.3 13.9 7.9 26.9 0.0056 0.0095 0.0071
Mt3 6.94 0.03880 0.076 0.14 0.9 0.9 0.9 0.9 0.7328 0.4609 0.8946
Rpl13a 6.27 0.04630 0.088 -1.66 3.2 4.4 3.1 2.3 0.0223 0.0435 0.0002
Phenotypic differences between Thoracic and Cervical Propriospinal neurons. Significant differences in gene expression between LDPT and TPS neurons were
detected using a 2 way ANOVA (shown in bold at Time 1, 1-week; Time 2, 2-weeks; and Time 3, 4-weeks post-FG injection). Genes were analyzed for a significant
effect of level. P-values were then corrected for multiple testing, by applying the Benjamini-Hochberg FDR algorithm. A Welch’s t-test, was used to determine at
which specific time-point the difference in gene expression was significant. In the table above 2E-05 represents P values of 2 × 10
-5 and 2 E-06 represents a P
value of 2 × 10
-6. Significant post-hoc P values are shown in italics.
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Page 10 of 17same animals, survival times, and treatment used in the
previous study. Although the LDPT neuronal samples
were analyzed at different times than the TPS samples,
the tissue was prepared and treated together prior to
the final analysis. An advantage of this type of investiga-
tion is that we can directly compare the present data
with our previous findings of TPS neurons.
Most previous studies examining the genetic changes
of SSNs post-SCI have utilized in situ hybridization.
This method is able to resolve genetic changes at a cel-
l u l a rl e v e lb u to n l yi sa b l et oa n a l y z ear e l a t i v e l ys m a l l
number of selected genes [47,48]. While the current
study only utilized qRT-PCR to examine the changes
occurring in LDPT neurons post-axotomy, the use of
the PCR array plates in combination with custom-
designed primers for 28 additional genes allowed us to
evaluate the expression of 113 genes simultaneously
(See Additional File 1), 89 of which were shown to be
expressed in our LDPT samples.
Differential Response of LDPT and TPS Neurons to T9
Axotomy
This study set out to investigate the intrinsic response of
LDPT neurons to a T9 spinal cord transection. We
hypothesized that LDPT neurons would respond in a
manner similar to what we previously documented in
TPS neurons [15], but in a delayed manner due to the
greater distance between cell body and axotomy site.
However, the results of this study clearly demonstrate
that, instead of mounting the contiguous acute regen-
erative and apoptotic response seen in TPS neurons,
LDPT neurons initiate an overall down-regulation of
most of the significantly affected genes that were
examined.
Of the 11 genes examined in the present study that
are pro- or anti-apoptotic, the only two that were nom-
inally significant (Pycard and Casp2) are pro-apoptotic
but both were down-regulated. Anti-apoptotic genes
including Akt3, Bcl2, Il10 and Xiap [31-36] were unaf-
fected. Additionally, two genes involved in regulating
the formation of autophagic vesicles, Atg9a and Atg9b,
that can be involved in caspase-independent cell death
[37,38], also failed to show a significant change in
expression over the time course examined post-axot-
omy. This lack of a cell death response was also
supported by little TUNEL immunostaining or co-locali-
zation of TUNEL immunoreactivity within retrogradely
labelled LDPT neurons, at least 1-week post-SCI (Figure
3). TUNEL immunolabelling within retrogradely labelled
TPS neurons at the 1-week time point in the present
study also supports our previous findings of an early
apoptotic response in TPS neurons post-SCI [15]. More-
over, the caspase 3 immuno-reactivity found in pre-
labelled TPS neurons 1 week post-SCI in our previous
study (15) is not observed 1 week post-SCI in pre-
labelled LDPT neurons (unpublished observations).
An examination of the genes involved in cell stress/
neuroprotection and axonal regeneration revealed a con-
sistent up-regulation of Atf3, but only a transient up-
regulation of Hspb1 (Hsp27) in LDPT neurons post-
axotomy. Other genes encoding agents that enhance
neuronal survival or axonal regeneration were unaf-
fected (Zfp91, Mt3) or down-regulated (Ntf5, Tgfa,
Artn, Tgfb1). ATF-3 is a transcription factor that is
often elevated after axonal injury or inflammatory pro-
cesses. ATF-3 is up-regulated in dorsal root ganglion
(DRG) neurons after peripheral nerve injury, and is
down-regulated once regeneration is complete [49].
HSP-27 is a molecular chaperone involved in a number
of functions that promote neuronal survival, as well as
promoting axonal regeneration [50-52]. Hsp27 is a
downstream product of the dimerisation of ATF-3 and
c-Jun, another transcription factor usually up-regulated
after axotomy [53] that was not examined in the current
study. c-Jun has been associated with apoptosis, neuro-
nal survival, as well as regeneration [53]. The intrinsic
growth state of DRG neurons is increased, and Hsp27 is
more highly expressed in transgenic mice that over-
express ATF-3 [49]. These data suggest that ATF-3 reg-
ulates Hsp27 and both are involved in promoting axonal
growth. However, the divergence in the continued
expression of ATF-3, and down-regulation of Hsp-27 at
later time points in the current study differs from these
previous findings [49,53], and suggests that other factors
are involved. Further study is needed to determine the
role of these genes in the LDPT post-injury response, as
well as the level of expression of c-Jun at different times
after axotomy. c-Jun has been implicated as a pivotal
regulator of whether a neuron survives post-axotomy
but does not undergo a strong intrinsic regenerative
response, or a neuron initiates a strong regenerative
response as well as a cell death response, similar to the
result found for TPS neurons in our previous study
[15,53].
This stark contrast between the intrinsic LDPT and
TPS response to axotomy is illustrated in the heat map
shown in Figure 4. This heat map illustrates that while
TPS neurons mount a robust post-axotomy response,
most genes of LDPT neurons that were examined are
down-regulated for the entire post-SCI period examined.
These data suggest that LDPT neurons may enter a
state of relative quiescence or dormancy. One gene in
particular, hypocretin (orexin) neuropeptide precursor
(HcRt), is known to regulate energy metabolism in neu-
rons [54,55], among other functions, and, is significantly
down-regulated in LDPT neurons but up-regulated in
TPS neurons following axotomy. Several neurotrophic
factors (Atrn, Ntf3, Ntf5) are down-regulated. There is
Siebert et al. BMC Neuroscience 2010, 11:148
http://www.biomedcentral.com/1471-2202/11/148
Page 11 of 17the simultaneous down-regulation of genes for a num-
ber of neurotrophic factor receptors (Gfra3, Gfra2,
Gfra1, Ntrk1, and Adcyap1r1). This down-regulation is
likely to make LDPT neurons less responsive to these
neurotrophic factors. A second possibility for the down-
regulation of the surface receptors is that the decrease
in mRNA expression is due to the stabilization of the
receptor proteins which, in turn, could down-regulate
new synthesis of these receptors. As Figure 4 shows, this
down-regulation is completely different from the
response of TPS neurons post-low thoracic SCI found
in our previous study [15]. While these disparate effects
of thoracic SCI/axotomy on LDPT and TPS neurons is
quite clear, what remains unresolved is the reason for
this differential response.
Factors contributing to the differences in the intrinsic
response of LDPT and TPS neurons to low thoracic
axotomy
One likely possible explanation for the differential
effects of low thoracic axotomy on the cellular response
of LDPT and TPS neurons is the distance between the
site of the axotomy and the cell body of the neuron
[47,56,57]. The present study specifically analyzed neu-
rons collected from the C5-C6 level spinal cord, 11 seg-
ments rostral to the lesion site, whereas TPS neurons
were collected from the T6-T7 spinal level, two seg-
ments rostral (approximately 2 mm) to the lesion. With
axotomy occurring at the T9 level, TPS neurons also are
located near the lesion site with the associated inflam-
matory and immune responses that occur in this region,
and many of the genes most highly up-regulated in the
microarray analysis of TPS neurons post-injury were
related to inflammation [15]. Previous work indicates
one result of inflammation and invasion of vascular
macrophages [48,56-63] is a neuroprotective response
that also may be needed to stimulate a maximal regen-
erative response [62,63] fostering successful regeneration
within PNS implants [64-66] and within the central ner-
vous system, itself [48]. For this reason, it is difficult to
separate the inflammatory effect of proximal injury,
from the effects of axotomy close to the cell body being
primarily responsible for the differential response com-
paring TPS and LDPT neurons in our analyses.
One study attempting to separate the inflammatory
response from site of axotomy was conducted by Hous-
sain-Ibraham and colleagues [48] in a study of corti-
cospinal tract (CST) neurons. Lipopolysaccharide (LPS),
an inflammatory reagent, was applied to the cerebral
cortex near the cell bodies of spinally axotomized CST
neurons. LPS resulted in increased expression of a num-
ber of regenerative associated genes (e.g., Gap-43, Scg10,
and Chl1) in CST neurons, although this regenerative
response did not contribute to sprouting or regeneration
of CST axons damaged in the spinal cord at the time of
LPS application [48]. It would be interesting to deter-
mine if the application of LPS (or another inflammatory
agent) into the cervical enlargement would elicit a
response in LDPT neurons after thoracic axotomy that
mirrors the response observed in TPS neurons. The role
Figure 4 Comparative post-injury response. The expression
profiles illustrate the normalized -ΔΔCp expression values of the
post-injury response for both the TPS and LDPT neurons at the
same survival times as in Figure 1 and numbered 1-4, with low
expression values being represented by green and high expression
in red. Significant changes in expression were determined using a
2-factor ANOVA, and then cluster analysis to reveal patterns in the
expression profiles. As illustrated in this heat map, the differences in
the post-injury response are striking. While many of the genes in
LDPT neurons are down-regulated following a T9 level axotomy, the
opposite is found in TPS neurons were there is a strong up-
regulation following axotomy. The data illustrated in this heat map
clearly demonstrate a differential response to a T9 level axotomy.
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also been demonstrated for retinal ganglion cell (RGC)
axons and the dorsal root process of dorsal root gang-
lion (DRG) neurons. Both classes of axon grow poorly
within peripheral nerve grafts unless the site of axotomy
is near their cell bodies of origin [67]. This regenerative
response is enhanced by an inflammatory response eli-
cited by lens injury or other perturbation (RGCs), or
injection of an inflammatory agent near DRG neurons
[59,62,68]. Taken together, these findings, in combina-
tion with our previous study [15], support the hypoth-
esis that an inflammatory response may play an
important role in the ability of CNS neurons to mount a
regenerative response.
If on the other hand, the post-injury response
observed in the TPS neurons was primarily the result of
the axotomy occurring closer to the cell body of the
neuron [2,47,56,57] it is reasonable to expect that SCI
causing axotomy nearer to the cell body of LDPT neu-
rons should mount a cellular response similar to TPS
neurons after low thoracic SCI. Previous work with
SSNs supports this idea. An early regenerative response,
marked by the up-regulation of growth associated genes
(i.e. Atf3, Jun, and Gap43), occurs in CST neurons fol-
lowing axotomy near the cell body that is not found
after spinal axotomy [21,57]. An early regenerative
response is also seen within rubrospinal tract neurons
following cervical axotomy that does not occur after
thoracic axotomy [47].
Phenotypic Differences Between Uninjured LDPT and TPS
Neurons
A third possibility to explain the differences in the cellu-
lar response post-axotomy of TPS and LDPT neurons is
a basic difference in the normal expression of genes
involved in apoptosis, neuroprotection, regeneration
associated genes, etc. that could influence the cellular
response post-axotomy. As discussed above, large differ-
ences were found when the uninjured control data from
both the LDPT and TPS neurons were compared. These
results are both interesting and unexpected, although
there are a number of fundamental differences between
these two populations of PS neuron. One obvious differ-
ence is the length of the axonal projections of these two
classes of neuron and the differing metabolic needs to
maintain them. For instance, many neurodegenerative
diseases result from axonal transport defects, and long
tract axons are the population susceptible to these dis-
eases [69]. LDPT neurons are located within the inter-
mediate gray matter of the cervical enlargement, and
project their axons caudally for many spinal segments
terminating within the intermediate gray matter of the
lumbosacral enlargement [10,70]. TPS neurons, on the
other hand, arise from the thoracic spinal gray matter,
and project their axons for shorter distances in either
the rostral or caudal direction [10,70]. These differences
in axonal length, alone, could explain the generally
higher expression of many of the neurotrophic genes
and their receptors that were found in LDPT neurons
compared to their TPS counterparts. Of the genes
demonstrating a significant difference in expression
between the cervical (LDPT neurons) and thoracic levels
(TPS neurons) of the spinal cord, over 90% show a sig-
nificantly higher expression in LDPT neurons. These
genes included potent neurotrophic factors (Artn, Ntf5),
neurotrophic factor receptors (Cntfr, Gfra1, Gfra2, Lifr,
Ntrk1, and Ntrk2), or other molecules known to be
involved with neural protection and cellular stress/axo-
nal maintenance (Hspb1, Nf1, Zfp91). Therefore the
increased expression of these neurotrophic agents and
neurotrophic/growth factor receptors in LDPT neurons
may be related to their axonal length, function, and
maintenance. A second potential difference between
these two subclasses of PS neuron, associated with the
length of their projections, is the greater possibility of
collateral projections of these axons between the cell
body and point of axotomy. The lack of or down-regula-
tion in the expression of the effected genes may be the
result of “sustaining collaterals”. Such collaterals could
interfere with a significant regenerative response,
because the neuron is still receiving adequate trophic
support. Similarly, the axonal projections of many SSNs,
such as the CST, form collateral projections rostral to
the spinal cord, and this may be one reason for the lack
of regenerative response of Purkinje cell axons, even
with axotomy close to the cell body, because of their
prominent recurrent collaterals [71].
The significant difference in expression of the refer-
ence genes (Rplp1, Ldha, Hprt, and Rpl13a) is also intri-
guing. These data are unlikely to be a plate loading or
cell concentration artifact, since a closer examination of
the -ΔΔCp values reveals two of the reference genes,
Rplp1 and Rpl13a, to be higher in LDPT than TPS neu-
rons, while the other two reference genes, Ldha and
H p r t ,a r ef o u n dt ob em o r eh i g h l ye x p r e s s e di nT P S
than in LDPT neurons. If the difference in expression of
the reference genes was the result of a plate or cell load-
ing artifact, these differences in expression should be
homologous, with all four reference genes having change
in the same direction (all significantly increased or
decreased). However both ribosomal protein genes, ribo-
somal protein, large P (Rplp1) and ribosomal protein
L13a (Rpl13a) were increased in LDPT neurons when
compared to TPS neurons, while lactate dehydrogenase
A (Ldha) and hypoxanthine phosphoribosyltransferase 1
(Hprt) demonstrated a higher expression in TPS neu-
rons. Moreover, other PCR plate controls showed simi-
lar values for the LDPT and TPS findings (data not
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ence genes between samples indicate a further phenoty-
pic difference between these two subsets of PS neurons.
Therapeutic Implications for LDPT Neurons
The lack of a regenerative response and massive down-
regulation of genes that occurs in LDPT neurons after
T9 level SCI, is in stark contrast to that found in TPS
neurons after the same injury. The lack of any indica-
tion of a cell death response either immediately or dur-
ing the first month post-injury is similar to what is
found after spinal axotomy for most SSNs where neuro-
nal atrophy occurs over time, and cell loss occurs
slowly, if at all [72-74].
Previous studies have documented the advantage PS
neurons have over SSNs, in their regenerative ability after
spinal cord injury [3,7,74,75]. In all of these instances, PS
n e u r o n sw e r en e a rt h el e s i o ns i t ea n da b l et or e g e n e r a t e
their axons into permissive environments such as periph-
eral nerve implants or other trophic molecule enriched
implants. Our findings in the current study, while sur-
prising, suggest that following thoracic axotomy, the
response of LDPT neurons may be more similar to the
response seen after spinal axotomy in SSNs. It is pre-
sently unknown if LDPT neurons atrophy or are lost at
longer survival times post-thoracic axotomy. From pre-
vious findings by others described above, a stronger
regenerative response might occur if LDPT neurons were
axotomized and/or an inflammatory response occurred
nearer their cell bodies at the same time as axotomy
To determine the neurotrophic or growth factor(s)
that would be most effective in potentially fostering a
regenerative response, we analyzed surface receptor and
growth factor expression profiles (Figure 4). We found
the simultaneous down-regulation of three out of the
four receptors of the GDNF family (Gfra1, Gfra2,
Gfra3), as well as the down regulation of Ntrk1 (TrkA)
and the Adcyap1r1 receptor. Iannotti and colleagues
have shown GDNF to enhance axonal growth of PS
neurons within implants, and that intrathecal application
of GDNF to a SCI lesion site is neuroprotective [8].
However, in the case of thoracic axotomy of LDPT neu-
r o n s ,o u rd a t ai n d i c a t et h a tG D N Fi su n l i k e l yt ob et h e
neurotrophic agent of choice. Additionally the down-
regulation of the NGF receptor, Ntrk1 (TrkA) argues
against the use of nerve growth factor (NGF) as a poten-
tial therapeutic agent. In fact, supplying a neurotrophic
agent to a neuron without the appropriate receptors can
be harmful. For instance, when sympathetic neurons,
expressing p75 and TrkA surface receptors, were pre-
sented with the neurotrophic molecule BDNF, subse-
quent binding of BDNF to the p75NTR without binding
to TrkB ultimately led to the death of the neurons via
p75NTR induced apoptosis [76,77].
Even though our present study revealed a down-regu-
lation of three receptors of the GDNF family [78,79]
and Ntrk1, genes for other growth factor receptors that
did not demonstrate a change in expression may provide
clues as to which neurotrophic agents might prove use-
ful for LDPT axonal regeneration. Our analysis revealed
no significant difference in the expression of Lifr, a
receptor for LIF and a co-receptor for CNTF, or Cntfr,
the primary receptor for CNTF. Previous studies have
demonstrated both LIF and CNTF to be important
growth factors responsible for stimulating axonal regen-
eration [80-82]. Additionally we found no significant
change in the post-axotomy expression of Ntrk2 (TrkB;
the primary BDNF receptor) and Ntrk3 (TrkC/NT-3;
neurotrophin 3). These neurotrophins have also been
reported to be highly neuroprotective and/or promote
axonal sprouting/regeneration in other classes of neu-
rons, including SSNs [3,74,75]. Additionally, we found
that Lifr, Cntfr, and Ntrk2 are significantly more highly
expressed in uninjured LDPT neurons than in TPS neu-
rons. This may indicate that these previously discussed
therapeutic agents may be especially beneficial for LDPT
neurons. The nominal down regulation of Pycard and
Casp2, lack of a significant effect on the expression of
Atg9a, Atg9b, Bax, or Tp53 and lack of any TUNEL
immunostaining post-SCI, strongly suggests that LDPT
neurons do not undergoing apoptosis during the first
month post-thoracic SCI. These findings suggest that
delivering the suggested neurotrophic agents at a higher
level to LDPT neurons than are normally present post-
SCI may have potential therapeutic benefit during the
first month following thoracic SCI.
Conclusions
Previous studies have demonstrated the ability of PS axons
to grow into peripheral nerve implants and neurotrophin
enriched bridges, form functional new neuronal bypass
circuits around an incomplete lesion, and cross the mid-
line to form new circuits [7,8,83-85]. Additionally, our pre-
vious findings show an initial robust intrinsic response of
TPS neurons to a low T9 level axotomy [15]. The current
study, combining qRT-PCR with immunofluoresence data
demonstrate that LDPT neurons respond more like SSNs
than TPS neurons following a low thoracic axotomy. The
down-regulation of many genes, including growth factors,
neurotrophic/growth factor surface receptors, and cell
death elements, is surprising based on the multitude of
reports indicating the robust regenerative response of PS
neurons. However, this intrinsic cellular response of LDPT
neurons may result from the axotomy occurring many
segments from LDPT neurons. The current study also
demonstrates a fundamental difference in the baseline
expression of many of the genes evaluated when LDPT
and TPS neurons are compared. Our data indicate that
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pletely different than their thoracic counterparts following
spinal injury, since there are significant differences in their
post-axotomy response to thoracic SCI (see Figure 4).
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